_causes-and-drug-development-in-ataxia-telangiectasia.jpg "Causes and drug development in ataxia telangiectasia from ataxia telangiectasia Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 5 min 22 sec
✓ Published: 22-Jan-2018
✓ Published: 22-Jan-2018
Description:
Dr Richard Gatti meets with ecancertv to discuss Ataxia telangiectasia (AT), a rare, and some times lethal, disorder in children where one out of three develops malignancy by the age of ten.nnDr Gatti notes that children with AT have a very strong cancer predisposition because they are missing the ATM protein which causes cell death by apoptosis; however, it is still unclear has to how this results in the development of cancer cells. Dr Gatti is currently working on the development of a group of
Dr Richard Gatti meets with ecancertv to discuss Ataxia telangiectasia (AT), a rare, and some times lethal, disorder in children where one out of three develops malignancy by the age of ten.nnDr Gatti notes that children with AT have a very strong cancer predisposition because they are missing the ATM protein which causes cell death by apoptosis; however, it is still unclear has to how this results in the development of cancer cells. Dr Gatti is currently working on the development of a group of
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_safety-and-efficacy-of-the-oral-atr-inhibitor-elimusertib-in-advanced-solid-tumours-with-dna-damage-response-defects.webp "Dr Timothy Yap speaks to ecancer as part of the AACR 2022 meeting about a study evaluating the safety and efficacy of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor elimusertib in advanced solid tumours with DNA damage response defects.nnHe reports that clinical benefit with disease control for at least 16 weeks was achieved in at least 35% of patients treated with elimusertib and that durable responses were seen over a variety of cancer types. nnDr Yap also explains that the ad")
⏲ 2 min 49 sec ✓ 11-Apr-2022
_lee.webp "Ataxia telangiectasia is a rare neurodegenerative disease, one that has left Lee severely disabled. But not one that makes him sad or unhappy with life, as thankfully he has a family who care and are there for him and all his needs… Meet Lee and A.T.")
_silicon-valley-prayer-breakfast-2010-03-31.webp "The 2010 event featured Joe Ehrmann, former NFL player, coach, and community leader, and Tim Borland, president of Race for Good. The theme of the event was")
_imagin-at-film.webp "Dr Jayesh Bhatt and Dr Andrew Prayle talk about their IMAGIN-AT research project at Nottingham University Hospital")
_ataxia-telangiectasia-overview-and-immunologist-role.webp "Ataxia-telangiectasia: overview and immunologist role from ataxia telangiectasia")
_longitudinal-brain-changes-in-childhood-a-t.webp "Dr Rob Dineen talks about his latest Ataxia Telangiectasia (A-T) research project at the University of Nottingham.")
_combination-of-camonsertib-plus-parpi-shows-clinical-activity-in-ddr-aberrant-tumours.webp "Dr Timothy Yap speaks to ecancer about the safety and efficacy of three PARP inhibitors combined with the ataxia telangiectasia- and Rad3-related kinase inhibitor camonsertib, in patients with solid tumours harbouring DNA damage response alterations.nnThe study explored patients (≥ 18 yrs) with relapsed/refractory solid tumours with DDR alterations which were treated with camonsertib plus talazoparib, niraparib, or olaparib in 2 phase I trials.nnThe combination of camonsertib plus PARPi at low")
⏲ 3 min 28 sec ✓ 21-Apr-2023
_identifying-new-therapies-for-blood-cancers-in-patients-with-a-t.webp "Research project at the University of Birmingham to identify new therapies for treating blood cancers in patients with Ataxia Telangiectasia (A-T)")
_safety-and-efficacy-of-the-oral-atr-inhibitor-elimusertib-in-advanced-solid-tumours-with-dna-damage-response-defects.jpg)
_lee.jpg)
_silicon-valley-prayer-breakfast-2010-03-31.jpg)
_imagin-at-film.jpg)
_ataxia-telangiectasia-overview-and-immunologist-role.jpg)
_longitudinal-brain-changes-in-childhood-a-t.jpg)
_combination-of-camonsertib-plus-parpi-shows-clinical-activity-in-ddr-aberrant-tumours.jpg)
_identifying-new-therapies-for-blood-cancers-in-patients-with-a-t.jpg)
![[+]](/images/menu.gif){kind=small}